ADHD |
Attention-deficit/hyperactivity disorder |
AMPK |
AMP-activated protein kinase |
BBB |
Blood-brain barrier |
CI |
Confidence interval |
COPD |
Chronic obstructive pulmonary disease |
DALYs |
Disability-adjusted life years |
DUOX1 |
Dual oxidase 1 |
GBD |
Global Burden of Disease |
GSH |
Glutathione |
HR |
Hazard ratio |
ICAM-1 |
Intercellular adhesion molecule 1 |
IL |
Interleukin |
IFN-γ |
Interferon gamma |
iNOS |
Inducible nitric oxide synthase |
IRR |
Incidence rate ratio |
LDL |
Low-density lipoprotein |
MCP-1 |
Monocyte chemotactic protein 1 (CCL2) |
MDA |
Malondialdehyde |
NADPH |
Nicotinamide adenine dinucleotide phosphate |
NF-κB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
NLRP3 |
NLR family pyrin domain containing 3 |
NO |
Nitric oxide |
NOX |
NADPH oxidase isoform |
Nrf2 |
Nuclear factor E2 related factor-2 |
OR |
Odds ratio |
PPAR γ |
Peroxisome proliferator-activated receptor gamma |
p47phox |
Regulatory subunit of NOX-2 and NOX-1 |
ROS |
Reactive oxygen species |
RR |
Relative risk |
SOD |
Superoxide dismutase |
TGF- β |
Transforming growth factor beta |
TNFα |
Tumor necrosis factor alpha |
Trx |
Thioredoxin |
US |
United States |
VCAM-1 |
Vascular cell adhesion molecule 1 |
WHO |
World Health Organization |